Nutrient offers hope to stop deadly march toward cirrhosis, liver cancer

April 19, 2017
Credit: CC0 Public Domain

A new study suggests that one type of omega 3 fatty acid offers people who are obese or have a poor diet a chance to avoid serious liver damage.

This is something that no available drug can accomplish, and can otherwise only be obtained by significant weight loss based on a very healthy diet.

The findings, published by researchers from Oregon State University today in PLOS ONE, were based on a study done with laboratory animals. They could be significant, researchers say, since millions of people in the developed world try, and fail, to sustain weight loss or eat an optimal diet.

Supplements of DHA, one of the most critically important of the omega 3 fatty acids, were shown to stop the progression of nonalcoholic steatohepatitis, or NASH, into more serious and life-threatening health problems such as cirrhosis or cancer. This took place even with the continued consumption in lab animals of what scientists call a "western" diet - one that's high in fat, sugar and cholesterol.

NASH, which is characterized by liver inflammation, oxidative stress and fibrosis, is a substantial risk factor for cirrhosis and . It's predicted to be the leading cause of liver transplants by 2020, and the FDA currently has no approved medical treatments for it.

Based in large part on consuming the "," nearly 80 million adults and 13 million children in the United States are obese, and about 30 percent of the nation's population is estimated to have some form of chronic .

"Considering there are no FDA-approved ways to stop NASH progression, other than therapy, this supplement may be of significant help," said Donald Jump, a professor in the OSU College of Public Health and Human Sciences, and principal investigator with the Linus Pauling Institute.

"In the time frame that we studied, DHA supplementation was not able to achieve full remission of NASH, but it did stop it from getting worse. NASH is a serious disease, an enormous health care cost and we need to put the brakes on it. There's clear evidence this might help."

Over one 10-year study period, cirrhosis and liver-related deaths occurred in 20 percent and 12 percent of NASH patients, respectively.

Research has also shown that when humans with NASH are examined, they have very low levels of omega 3 fatty acids. When those levels are raised, the disease progression stops.

Omega 3 fatty acids regulate important biological pathways, including , oxidation, and breakdown of triglycerides, or fats in the blood. A natural nutrient, DHA appears to be one of the most significant of the omega 3 , and plays a role in repairing liver damage.

The highest levels of DHA are found in oily fish such as salmon, mackerel, tuna and sardines, and to a much lesser extent in some foods such as poultry, liver, egg yolks, and some types of algae. DHA is also increasingly being included in some prenatal vitamin and mineral formulas because of studies showing its critical importance to a developing fetus.

The current medical approach to NASH is based on lifestyle management, including diet and exercise. If successful and sustained, research indicates such approaches can completely reverse . However, in this study researchers noted that "this treatment, while ideal for clinical use, is likely not sustainable in NASH patients due to poor compliance."

EPA, another valuable omega 3 fatty acid, has not been found to lower liver fat and fibrosis in humans, Jump said, probably due to the poor conversion in humans of EPA to DHA.

DHA is a readily available supplement and safe to use, researchers say. Referring to the use of DHA supplementation to address problems with NASH, the researchers said in their report that, "This scenario will likely be used clinically since patient compliance to low-fat, low-sucrose dietary recommendations has historically been poor."

Explore further: Some omega-3 oils better than others for protection against liver disease

More information: PLOS ONE (2017). DOI: 10.1371/journal.pone.0173376

Related Stories

Some omega-3 oils better than others for protection against liver disease

February 5, 2013
(Medical Xpress)—Research at Oregon State University has found that one particular omega-3 fatty acid has a powerful effect in preventing liver inflammation and fibrosis – common problems that are steadily rising along ...

Diet and exercise can improve kidney function in patients with fatty liver disease

November 21, 2016
Non-alcoholic steatohepatitis (NASH) is a potentially serious liver condition characterized by excess fat in the liver associated with inflammation and scarring. NASH may progress to cirrhosis of the liver and liver cancer, ...

Fatty liver: Turning off TAZ reverses disease

October 27, 2016
Scientists at Columbia University Medical Center (CUMC) have identified a factor in liver cells that is responsible for turning a relatively benign liver condition, present in 30 percent of U.S. adults, into a serious disease ...

NASH associated with a 50 percent higher chance of death compared with NAFLD

April 24, 2015
Results from a large population-based cohort of almost a million people in the UK found that the chances of dying from non-alcoholic steatohepatitis (NASH), over a 14-year period, was approximately 50% higher than for those ...

More benefits emerging for one type of omega-3 fatty acid: DHA

January 23, 2014
A study of the metabolic effects of omega-3 fatty acids, especially DHA, concludes that these compounds may have an even wider range of biological impacts than previously considered, and suggests they could be of significant ...

Hormone identified that limits liver fibrosis

October 13, 2016
Nonalcoholic steatohepatitis (NASH) has been emerging worldwide and effective treatment, especially for liver fibrosis, is essential for improving the prognosis. A Japanese research team has identified and clarified the mechanism ...

Recommended for you

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

Raccoon roundworm—a hidden human parasite?

July 24, 2017
The raccoon that topples your trashcan and pillages your garden may leave more than just a mess. More likely than not, it also contaminates your yard with parasites—most notably, raccoon roundworms (Baylisascaris procyonis).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.